USE OF TANSHINONE DERIVATES AS CHOLINESTERASE INHIBITORS IN TREATING RELATED DISEASES
This present invention provides a new use of tanshinone derivatives as acetylcholinesterase inhibitors and in treating diseases associated with the depletion of acetylcholine such as cognitive impairment including Alzheimer's disease, insomnia, vascular dementia, memory loss, disorders of atten...
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | WAN, DAVID, CHIONG SHAW, PANGUI FUNG, KWOK-PUI HO, MICHELLE TSZ-WAN |
description | This present invention provides a new use of tanshinone derivatives as acetylcholinesterase inhibitors and in treating diseases associated with the depletion of acetylcholine such as cognitive impairment including Alzheimer's disease, insomnia, vascular dementia, memory loss, disorders of attention, and other sleeping disorders. The active compounds are commonly found in the root of Salvia genus, particularly Salvia miltiorrhiza, Danshen.
L'invention concerne une nouvelle utilisation de dérivés de tanshinone en tant qu'inhibiteurs d'acétylcholinestérase et pour le traitement de maladies associées à l'appauvrissement en acétylcholine telles qu'un déficit cognitif, y compris la maladie d'Alzheimer, l'insomnie, les troubles cérébraux vasculaires, les pertes de mémoire, les troubles de l'attention ou d'autres troubles du sommeil. On trouve communément les composés actifs dans la racine du genre Salvia en particulier, Salvia miltiorrhiza, Danshen. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2004084884A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2004084884A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2004084884A13</originalsourceid><addsrcrecordid>eNqNy7EKwjAQxvEsDqK-w4GzEDVD1thczUFJIHetYykSJ9FCfX_M4AM4ff_h961V3zNCakFc5EAxRQSPmQYnyOAYmpA6isiC2VVJMdCFJGWuCZLRCcUrZOzqwYMnxsp4q1aP6bmU3W83at-iNOFQ5vdYlnm6l1f5jLd00tpoa6w17nj-T30BNIYxhw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>USE OF TANSHINONE DERIVATES AS CHOLINESTERASE INHIBITORS IN TREATING RELATED DISEASES</title><source>esp@cenet</source><creator>WAN, DAVID, CHIONG ; SHAW, PANGUI ; FUNG, KWOK-PUI ; HO, MICHELLE TSZ-WAN</creator><creatorcontrib>WAN, DAVID, CHIONG ; SHAW, PANGUI ; FUNG, KWOK-PUI ; HO, MICHELLE TSZ-WAN</creatorcontrib><description>This present invention provides a new use of tanshinone derivatives as acetylcholinesterase inhibitors and in treating diseases associated with the depletion of acetylcholine such as cognitive impairment including Alzheimer's disease, insomnia, vascular dementia, memory loss, disorders of attention, and other sleeping disorders. The active compounds are commonly found in the root of Salvia genus, particularly Salvia miltiorrhiza, Danshen.
L'invention concerne une nouvelle utilisation de dérivés de tanshinone en tant qu'inhibiteurs d'acétylcholinestérase et pour le traitement de maladies associées à l'appauvrissement en acétylcholine telles qu'un déficit cognitif, y compris la maladie d'Alzheimer, l'insomnie, les troubles cérébraux vasculaires, les pertes de mémoire, les troubles de l'attention ou d'autres troubles du sommeil. On trouve communément les composés actifs dans la racine du genre Salvia en particulier, Salvia miltiorrhiza, Danshen.</description><edition>7</edition><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2004</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20041007&DB=EPODOC&CC=WO&NR=2004084884A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20041007&DB=EPODOC&CC=WO&NR=2004084884A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>WAN, DAVID, CHIONG</creatorcontrib><creatorcontrib>SHAW, PANGUI</creatorcontrib><creatorcontrib>FUNG, KWOK-PUI</creatorcontrib><creatorcontrib>HO, MICHELLE TSZ-WAN</creatorcontrib><title>USE OF TANSHINONE DERIVATES AS CHOLINESTERASE INHIBITORS IN TREATING RELATED DISEASES</title><description>This present invention provides a new use of tanshinone derivatives as acetylcholinesterase inhibitors and in treating diseases associated with the depletion of acetylcholine such as cognitive impairment including Alzheimer's disease, insomnia, vascular dementia, memory loss, disorders of attention, and other sleeping disorders. The active compounds are commonly found in the root of Salvia genus, particularly Salvia miltiorrhiza, Danshen.
L'invention concerne une nouvelle utilisation de dérivés de tanshinone en tant qu'inhibiteurs d'acétylcholinestérase et pour le traitement de maladies associées à l'appauvrissement en acétylcholine telles qu'un déficit cognitif, y compris la maladie d'Alzheimer, l'insomnie, les troubles cérébraux vasculaires, les pertes de mémoire, les troubles de l'attention ou d'autres troubles du sommeil. On trouve communément les composés actifs dans la racine du genre Salvia en particulier, Salvia miltiorrhiza, Danshen.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2004</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNy7EKwjAQxvEsDqK-w4GzEDVD1thczUFJIHetYykSJ9FCfX_M4AM4ff_h961V3zNCakFc5EAxRQSPmQYnyOAYmpA6isiC2VVJMdCFJGWuCZLRCcUrZOzqwYMnxsp4q1aP6bmU3W83at-iNOFQ5vdYlnm6l1f5jLd00tpoa6w17nj-T30BNIYxhw</recordid><startdate>20041007</startdate><enddate>20041007</enddate><creator>WAN, DAVID, CHIONG</creator><creator>SHAW, PANGUI</creator><creator>FUNG, KWOK-PUI</creator><creator>HO, MICHELLE TSZ-WAN</creator><scope>EVB</scope></search><sort><creationdate>20041007</creationdate><title>USE OF TANSHINONE DERIVATES AS CHOLINESTERASE INHIBITORS IN TREATING RELATED DISEASES</title><author>WAN, DAVID, CHIONG ; SHAW, PANGUI ; FUNG, KWOK-PUI ; HO, MICHELLE TSZ-WAN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2004084884A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2004</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>WAN, DAVID, CHIONG</creatorcontrib><creatorcontrib>SHAW, PANGUI</creatorcontrib><creatorcontrib>FUNG, KWOK-PUI</creatorcontrib><creatorcontrib>HO, MICHELLE TSZ-WAN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>WAN, DAVID, CHIONG</au><au>SHAW, PANGUI</au><au>FUNG, KWOK-PUI</au><au>HO, MICHELLE TSZ-WAN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>USE OF TANSHINONE DERIVATES AS CHOLINESTERASE INHIBITORS IN TREATING RELATED DISEASES</title><date>2004-10-07</date><risdate>2004</risdate><abstract>This present invention provides a new use of tanshinone derivatives as acetylcholinesterase inhibitors and in treating diseases associated with the depletion of acetylcholine such as cognitive impairment including Alzheimer's disease, insomnia, vascular dementia, memory loss, disorders of attention, and other sleeping disorders. The active compounds are commonly found in the root of Salvia genus, particularly Salvia miltiorrhiza, Danshen.
L'invention concerne une nouvelle utilisation de dérivés de tanshinone en tant qu'inhibiteurs d'acétylcholinestérase et pour le traitement de maladies associées à l'appauvrissement en acétylcholine telles qu'un déficit cognitif, y compris la maladie d'Alzheimer, l'insomnie, les troubles cérébraux vasculaires, les pertes de mémoire, les troubles de l'attention ou d'autres troubles du sommeil. On trouve communément les composés actifs dans la racine du genre Salvia en particulier, Salvia miltiorrhiza, Danshen.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; fre |
recordid | cdi_epo_espacenet_WO2004084884A1 |
source | esp@cenet |
subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | USE OF TANSHINONE DERIVATES AS CHOLINESTERASE INHIBITORS IN TREATING RELATED DISEASES |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T02%3A22%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=WAN,%20DAVID,%20CHIONG&rft.date=2004-10-07&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2004084884A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |